Latest News

Teva Announces Early Tender Results of its Debt Tender Offer, Increase of the Maximum Tender Amount ...

Teva Announces Early Tender Results of its Debt Tender Offer, Increase of the Maximum Tender Amount and E

Teva Becomes First Pharmaceutical Company to Execute Sustainability-linked Bond Tied to both Climate...

Teva Becomes First Pharmaceutical Company to Execute Sustainability-linked Bond Tied to both Climate and

Teva Announces Successful Upsize of Sustainability-Linked Senior Notes Offering and Pricing of $5,00...

Teva Announces Successful Upsize of Sustainability-Linked Senior Notes Offering and Pricing of $5,000,000

California Judge Rules That Teva Did Not Cause a Public Nuisance or Make False or Misleading Stateme...

California Judge Rules That Teva Did Not Cause a Public Nuisance or Make False or Misleading Statements A

New Phase 3 Data Presented at Psych Congress 2021 Showed TV-46000/mdc-IRM Significantly Prolonged Ti...

New Phase 3 Data Presented at Psych Congress 2021 Showed TV-46000/mdc-IRM Significantly Prolonged Time to

Teva Announces $3,500,000,000 Debt Tender Offers for Notes Due 2022-2024

Teva Announces $3,500,000,000 Debt Tender Offers for Notes Due 2022-2024

Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes

Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes

Teva Reports Third Quarter 2021 Financial Results

Teva Reports Third Quarter 2021 Financial Results

Teva and MODAG Announce Licensing Collaboration for Neurodegenerative Disease Drug Candidate

Teva and MODAG Announce Licensing Collaboration for Neurodegenerative Disease Drug Candidate

Teva to Present New Data from Growing Mental Health Portfolio at Psych Congress 2021

Teva to Present New Data from Growing Mental Health Portfolio at Psych Congress 2021

New Safety Data on treatment with COPAXONE® (glatiramer acetate) of Breastfeeding Mothers who Live w...

New Safety Data on treatment with COPAXONE® (glatiramer acetate) of Breastfeeding Mothers who Live with R

‘Medicine Miles’ Becoming a Concern for European Patients

‘Medicine Miles’ Becoming a Concern for European Patients

Teva to Host Conference Call to Discuss Third Quarter 2021 Financial Results at 8 a.m. ET on October...

Teva to Host Conference Call to Discuss Third Quarter 2021 Financial Results at 8 a.m. ET on October 27,

Teva to Present 8 Abstracts on AJOVY® (fremanezumab-vfrm) Injection and Hold Symposium on Healthcare...

Teva to Present 8 Abstracts on AJOVY® (fremanezumab-vfrm) Injection and Hold Symposium on Healthcare Disp

Teva Enlists Sarah Michelle Gellar to Launch “Inhaler Tales” Campaign to Raise Awareness About Inhal...

Teva Enlists Sarah Michelle Gellar to Launch “Inhaler Tales” Campaign to Raise Awareness About Inhaler Us